 | | | | (Reuters) - Shares of U.S. drug suppliers rose on Monday after a report that Amazon.com Inc had dropped plans to sell drugs to hospitals, in a boost to a pharmaceutical supply chain rattled by the looming threat of competition from the online retailer. | | |
| | | ZURICH (Reuters) - Roche's hemophilia A drug Hemlibra will get an accelerated review by U.S. regulators for use in a new group of patients, a key part of the Swiss drug company's plans to muscle in on turf dominated by rivals including Shire. | | |
| | | MEXICO CITY (Reuters) - The head of the International Coffee Organization criticized a U.S. judge's decision requiring cancer warnings on coffee sold in California by Starbucks and other retailers, expressing concern that the push for cancer labels may spread. | | |
| | | SHANGHAI (Reuters) - While China has made progress cutting smog, the damage to the health of millions of people may already have been done, especially as the population ages, the head of a U.S.-based research agency said. | | |
| | | (Reuters Health) - To lose weight, or just avoid gaining it, pasta is not one of the harmful carbs that needs to be sacrificed, researchers say. | | |
| | | LONDON (Reuters) - British Prime Minister Theresa May will pledge cash to help improve children's education in the Commonwealth and call for a commitment from fellow leaders to tackle malaria on Tuesday. | | |
| | | LONDON (Reuters) - Shire, the London-listed rare diseases specialist that is a potential takeover target for Japan's Takeda Pharmaceutical, is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion. | | |
| | | SAN FRANCISCO (Reuters) - Google told Reuters Monday it would resume accepting ads from U.S. addiction treatment centers in July, nearly a year after the Alphabet Inc unit suspended the lucrative category of advertisers for numerous deceptive and misleading ads. | | |
| | | NEW YORK (Reuters) - A $117 million verdict against Johnson & Johnson and a supplier in favor of a man who said his asbestos-related cancer was caused by long-term use of J&J's Baby Powder could open a new front for thousands of cases claiming the widely-used product caused cancer, legal experts and plaintiffs lawyers said. | | |
| | | (Reuters Health) - Most people have inaccurate beliefs about what cancer screening tests can do and what they cannot, suggests a recent study from the U.S. National Cancer Institute. | | |
|
| |
